Enavate Sciences GP, LLC / BBOT
Enavate Sciences GP, LLC’s Bridgebio Oncology Therapeut Position
Does Enavate Sciences GP, LLC own Bridgebio Oncology Therapeut (BBOT)? Yes — 2.63M shares worth $24M (+6.69% of its 13F portfolio) as of Q1 2026.
Position Value
$24M
Q1 2026
Shares
2.63M
% of Portfolio
+6.69%
Quarters Held
3
currently held
Position History BBOT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Enavate Sciences GP, LLC’s full portfolio or all institutional holders of BBOT.